Yablonsky Piotr, Pischik Vadim, Tovbina Marina G, Atiukov Mikhail
Faculty of Medicine, Saint Petersburg State University, St. Petersburg, Russia.
St. Petersburg City Hospital #2, St. Petersburg, Russia.
J Vis Surg. 2017 Aug 21;3:113. doi: 10.21037/jovs.2017.06.13. eCollection 2017.
During the period from 1996 to 2016, we have performed 281 thymectomies in patients with various diseases of the thymus. In 179 patients, thymic pathology was associated with autoimmune myasthenia gravis (MG), and, in 108 patients, thymoma was diagnosed.
The majority of surgeries [254] were performed using video thoracoscopy, 79 of them with an additional cervical approach. The long-term results of video thoracoscopic thymectomies in myasthenic patients were followed up for 1 to 15.5 years.
In 26% of the patients, a complete and stable remission was achieved, in 47%-clinical manifestation improved. Local recurrence of thymoma developed in one patient (0.9%).
Comparison of postoperative complications and long-term results demonstrated that extended video-assisted thoracoscopic thymectomy (VATS-TE) is a radical, efficient, safe, technically feasible and a well-tolerated surgery. It improves the course of MG as a part of multimodality treatment more efficiently than a conservative therapy alone. The course of MG after VATS-TE shows that the cumulative incidence of remissions/improvements reaches its maximum by the 3rd year after the surgery. VATS-TE is radical and safe for removal of noninvasive thymomas up to 8 cm in size. Additional neck incision (VATS-TE + cervical approach) does not provide further advantages, but rather may be a cause of specific postoperative complications.
1996年至2016年期间,我们对患有各种胸腺疾病的患者进行了281例胸腺切除术。179例患者的胸腺病理与自身免疫性重症肌无力(MG)相关,108例患者被诊断为胸腺瘤。
大多数手术[254例]采用电视胸腔镜进行,其中79例采用额外的颈部入路。对重症肌无力患者电视胸腔镜胸腺切除术的长期结果进行了1至15.5年的随访。
26%的患者实现了完全稳定的缓解,47%的患者临床表现有所改善。1例患者(0.9%)发生胸腺瘤局部复发。
术后并发症和长期结果的比较表明,扩大电视辅助胸腔镜胸腺切除术(VATS-TE)是一种根治性、高效、安全、技术上可行且耐受性良好的手术。作为多模式治疗的一部分,它比单纯保守治疗更有效地改善了MG的病程。VATS-TE术后MG的病程表明,缓解/改善的累积发生率在手术后第3年达到最高。VATS-TE对于切除直径达8 cm的非侵袭性胸腺瘤是根治性且安全的。额外的颈部切口(VATS-TE + 颈部入路)没有提供进一步的优势,反而可能是特定术后并发症的原因。